Kobe, Japan

Mizuho Kawate

This inventor holds 2 USPTO granted patents. Top assignee: Sysmex Corporation. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mizuho Kawate. Retrieved from https://idiyas.com/inventor/mizuho-kawate

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mizuho Kawate: Innovator in Nucleic Acid Analysis

Introduction

Mizuho Kawate is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of nucleic acid analysis, holding 2 patents that focus on innovative methods for analyzing genetic sequences. His work is crucial for advancements in medical diagnostics and personalized medicine.

Latest Patents

Kawate's latest patents include an analysis method for evaluating a nucleic acid sequence derived from patient samples. This method involves obtaining analysis data related to mutations based on nucleic acid sequence data and generating reports that differentiate between various types of mutations. Another patent focuses on a system for analyzing nucleic acid sequences of patient samples, which includes detecting somatic and germline mutations and presenting the results in a selected format.

Career Highlights

Mizuho Kawate is currently employed at Sysmex Corporation, where he continues to develop innovative solutions in the field of genetic analysis. His expertise in this area has positioned him as a key player in advancing diagnostic technologies.

Collaborations

Kawate collaborates with talented colleagues, including Kenichiro Suzuki and Reiko Watanabe, who contribute to his research and development efforts. Their teamwork enhances the innovative capabilities of their projects.

Conclusion

Mizuho Kawate's contributions to nucleic acid analysis exemplify the impact of innovation in medical technology. His patents and ongoing work at Sysmex Corporation are paving the way for improved diagnostic methods and personalized healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…